U.S. Software Stock News

With investors glued to upcoming US inflation data, oil price swings and firm Treasury yields, high dividend yield stocks are drawing fresh attention from anyone looking for steadier income while markets debate the Federal Reserve’s next move in September. This article looks at how those macro forces link back to company fundamentals and payout strength. You will see three stocks from the screener that appear positively exposed to the current backdrop. The three stocks highlighted below are...

Apnimed, Inc (NasdaqGS:APMD) has been added to the NASDAQ Composite Index following its recent IPO. The addition comes soon after Apnimed filed a shelf registration statement, signaling further corporate funding flexibility. Index inclusion typically draws attention from index-tracking funds and can affect trading volumes and liquidity. This kind of index move, combined with fresh IPO activity, points to a wider group of stocks that may be worth a closer look through 51 high quality...

FIFA’s leadership turmoil and talk of boycotts has put the business of global football under an uncomfortable spotlight, from billion dollar media rights to sponsorships tied to future World Cups. That disruption risk also creates an opening for investors watching sports media and broadcasting stocks exposed to this news. This article breaks down how three stocks from our screener are positioned, so you can judge whether the story fits your portfolio. The stocks covered below are just a...

Keel Infrastructure stock has delivered a very strong 176.4% return over the past year, yet the company only passes 1 of 6 valuation checks, which raises questions about how much of that performance is supported by fundamentals after recent setbacks. The 176.4% one year gain stands in sharp contrast to the recent pullback. This may signal that expectations built up faster than the market is now comfortable with. The shift away from U.S. Bitcoin mining toward AI and high performance computing...

Ingles Markets, Incorporated reported past third-quarter 2026 results with sales of US$1,368.32 million and net income of US$25.9 million, alongside higher nine‑month sales of US$4,049.16 million and net income of US$78.3 million versus the prior year. While quarterly earnings per share were almost unchanged, the nine‑month EPS from continuing operations rose to US$4.12, highlighting stronger year‑to‑date profitability despite a board resignation for personal reasons. We’ll now examine how...

GEO Group has delivered a very strong 317.1% return over the last three years, yet the shares now screen as overvalued on market multiples even while the broader valuation checks lean supportive. That mix of a big past gain with a richer pricing signal is what investors are trying to make sense of today. Over the last three years GEO Group has returned 317.1%, which puts a lot of past gains on the table and raises the bar for any new buyers at current levels. New federal immigration...

Penumbra, Inc. recently initiated a voluntary Class II recall of its Penumbra System RED 68 Reperfusion Catheter across multiple US states and international markets due to manufacturing issues that may cause catheter fractures, following firm notifications sent out in early June 2026. This recall comes shortly after Penumbra reported higher quarterly sales of US$390.05 million but lower net income of US$34.81 million and reduced earnings per share versus a year earlier, highlighting growing...

Sionna Therapeutics recently reported that its Phase 2a PreciSION CF trial of NBD1 stabilizer SION-719 added to Trikafta did not improve sweat chloride levels, leading the company to discontinue SION-719 as an add-on therapy and to reassess its clinical plans. At the same time, early data from SION-451 combination studies and a cash balance of about US$268.3 million give Sionna room to reconsider how it pursues cystic fibrosis therapies while preserving capital. We’ll now examine how...

As AI moves from buzzword to core toolkit for tracking inflation, jobs and growth in real time, investors are no longer limited to slow, revision prone government reports. That shift is creating a data gap between companies that power these new insights and everyone else, and missing it could mean missing the next big story. This article walks through three AI and data analytics stocks exposed to that news and explains why they stand out right now. The three stocks highlighted below are just...

Upbound Group (UPBD) recently reported second quarter 2026 results and updated its outlook, which appears to be the key driver for the latest stock move as investors reassess earnings quality and guidance. See our latest analysis for Upbound Group. The latest move in Upbound Group's share price, which is down 3.08% over the last day at $19.22 and down 9.17% over the past month, comes after second quarter earnings, refined revenue guidance, and confirmation that the buyback program has now...

Enpro Inc. reported its second-quarter 2026 results, with sales rising to US$338.8 million and net income reaching US$27.1 million, while also affirming a quarterly dividend of US$0.32 per share payable in September 2026. The company also raised its 2026 revenue growth outlook to a range of 14% to 16%, indicating increased confidence relative to its prior expectations. Now we’ll assess how Enpro’s higher 2026 revenue growth guidance may reshape the existing investment narrative built on...

A Harris County jury recently ordered 3M to pay US$61.5 million to Houston homeowners for its role in the 2020 Watson Grinding & Manufacturing explosion, after finding failures in servicing the facility’s gas detection and alarm systems contributed to the disaster. This third successful bellwether trial in the multi-district litigation highlights how 3M’s service practices for safety systems can translate into substantial legal liabilities and community impact. We’ll now examine how this...

With U.S. bond yields at multi year highs, inflation still above the Fed’s target, and markets second guessing what comes next under Kevin Warsh, interest rate sensitivity is firmly back in focus. That mix creates both risk and potential opportunity for investors watching how insurance stocks react to higher real yields. This article explains how the news relates to insurers and highlights 3 stocks from the screener to watch closely. The three insurers covered next are just a sample from this...

Why Ventas Stock Is Back in Focus After Q2 Earnings Ventas (VTR) drew fresh attention after releasing second quarter 2026 results, along with a higher senior housing investment target and a modestly raised full year earnings outlook, which together shaped recent investor sentiment. See our latest analysis for Ventas. Against this backdrop, Ventas shares closed at US$91.95 and have delivered an 18.91% year to date share price return. The 1 year total shareholder return of 37.65% and 3 year...

Rising chipflation and tight supply in servers and storage hardware are pulling future demand into today, as enterprises rush to lock in equipment before costs bite harder. That rush can create pricing power and margin pressure at the same time, which is exactly where opportunities often appear first. This article explains how the news affects three specific hardware stocks and why their exposure to this story matters for your portfolio watchlist. The stocks covered below are just a starting...

Executive hire and recent results put Evercore in focus Evercore (EVR) has drawn fresh attention after appointing Dylan Tornay as senior managing director in its equity capital markets group, alongside recent quarterly earnings and a confirmed dividend declaration. Tornay joins from Citi with nearly 30 years of equity capital markets experience. He will focus on industrials and infrastructure, areas that may matter for investors watching how Evercore positions its advisory and capital markets...

In early August 2026, ePlus Inc. reported Q1 FY27 results showing revenue of US$649.11 million and lower net income of US$30.28 million year on year, while reiterating mid-single-digit growth guidance for fiscal 2027 and declaring a quarterly dividend of US$0.27 per share. Management also highlighted that a strong balance sheet is allowing ePlus to keep funding organic growth, evaluate acquisitions, and return cash to shareholders through dividends and share repurchases, offering a mixed...

Diversified Healthcare Trust recently reported past second-quarter 2026 results, with sales of US$47.47 million and revenue of US$365.39 million, alongside a net loss of US$37.42 million and basic loss per share from continuing operations of US$0.16. Despite lower sales and revenue versus a year earlier, the trust reduced its net loss and loss per share, indicating that expense controls and operational adjustments are limiting the impact of softer top-line performance. We’ll now examine how...

Standex International (SXI) has moved into focus after reporting higher quarterly and full year sales and net income, alongside guidance that points to further organic growth and an expanded new product pipeline in fiscal 2027. See our latest analysis for Standex International. Against this backdrop, Standex International's share price has climbed strongly, with a 90 day share price return of 28.68% and a year to date share price return of 45.93%. The 1 year total shareholder return of 75.26%...

Teledyne Technologies (TDY) has agreed to acquire Varex Imaging in an all cash transaction valued at about US$1.1b, offering US$18.90 per Varex share. This move adds oncology focused X-ray detectors to Teledyne's portfolio. See our latest analysis for Teledyne Technologies. At a share price of US$690.25, Teledyne Technologies has posted a 30 day share price return of 8.77% and a year to date share price return of 33.06%. The 3 year total shareholder return of 71.49% points to sustained...

Intellia Therapeutics (NTLA) reported Q2 2026 results that kept the company in loss making territory, although the net loss and loss per share for both the quarter and first half improved versus last year. See our latest analysis for Intellia Therapeutics. Intellia Therapeutics’ latest earnings release on 6 August came after a period where the stock’s year to date share price return of 30.51% is set against a 1 year total shareholder return of 11.92% and a 3 year total shareholder return that...

Edison International earnings and guidance update Edison International (EIX) has released second quarter 2026 results that combine higher quarterly net income with revised, lower full year earnings guidance, giving investors fresh numbers to assess the stock. See our latest analysis for Edison International. The share price reaction around the earnings release has been weak, with Edison International down 5.1% over the past week and 9.8% over the past month, even though the year to date share...

We wouldn't blame Griffon Corporation ( NYSE:GFF ) shareholders if they were a little worried about the fact that...

N-able, Inc. recently reported its Q2 2026 results, shifting from a net loss of US$4.63 million a year ago to net income of US$1.76 million and issuing Q3 and full-year 2026 revenue guidance of US$134.5–US$135.5 million and US$539–US$542 million, respectively. Management highlighted Data Protection as a key driver of new annual recurring revenue and credited AI-generated code, now almost half of committed code, for improving development productivity, even as weaker renewal rates in UEM and...